2002-02-22
2003-04-01
Carr, Deborah D. (Department: 1621)
Reexamination Certificate
active
06540654
ABSTRACT:
BACKGROUND OF THE INVENTION
The carotenoids are important natural products which are involved in the photosynthetic process of plants. Carotenoids are used as nutritional supplements for animals and humans, as well as in food colorants and cosmetics. Although carotenoids are important for health, animals and humans cannot produce them, and these compounds must thus be obtained through diet from fruits and vegetables.
Several properties of the carotenoids make them important for the health of both animals and humans. For example, these compounds are antioxidants with important quenching effects on free radicals. They protect living tissues against a variety of diseases, either directly or as immunopotentiators. Additionally, carotenoids are involved in gap-junction communication among living cells. Recent epidemiological evidence has suggested an inverse relationship between the consumption of fruits and vegetables with high carotenoid content and the incidence of several types of cancers. Specifically, &bgr;-carotene, lutein and lycopene have been shown to exhibit a cancer-prevention effect (M. M. Mathews-Roth,
Current Chemotherapy and Infectious Diseases
(J. D. Nelson and C. Grassi, Eds, Am. Soc. Microbiol., Washington D.C.:1503-1505(1980)); B. P. Chew et al,
Anticancer Research
16:3689-3694 (1996); P. H. Gann et al,
Cancer Res.
59:1225-1230 (1999)).
Additionally, several carotenoids, such as lutein and zeaxanthin, have specific functions in the retina of the eye to assure healthy vision in several animal species, including humans (J. D. Landrum et al.,
Archives Biochem. Biophys.
385(1):28-40(2001)). Finally, some carotenoids have pro-vitamin A activity, whereas others control reproduction and fertility, upregulate the Connexin43 gene, decrease the risk of degenerative disease and prevent coronary heart disease (N. Krinsky,
Pure and Appl. Chem.
66(5):1003-1010 (1994)).
From a chemical standpoint, carotenoids may be classified by their functional groups into several categories (see
Key to Carotenoids,
2nd enlarged and revised edition, H. Pfander et al, Birkhäuser Verlag, Basel, 1987). These include hydrocarbon carotenoids such as &bgr;-carotene and lycopene, monohydroxy carotenoids such as &bgr;-cryptoxanthin, dihydroxy carotenoids such as lutein and zeaxanthin, polyhydroxy carotenoids such as &bgr;,&bgr;-carotene triol, epoxycarotenoids such as violaxanthin and antheraxanthin, carbonyl carotenoids such as echinenone, capsanthin, canthaxanthin and astaxanthin, and carotenoid acids such as bixin and crocetin.
Esters with a carotenoid as the alcohol-derived moiety are well known. For example, the monoesters and diesters of lutein and zeaxanthin with palmitic acid, myristic acid and stearic acid occur in nature. They are also known as the “xanthophylls” of the flowers and leaves of most plants (Alam,
Lipids,
3:183 (1968)). These esters are also prepared commercially, as described, for example, in U.S. Pat. No. 6,191,293 of Levy via the extraction of the flowers of the marigold plant (
Tagetes erecta
) with subsequent purification.
Additionally, some esters containing a carotenoid as the alcohol-derived moiety have been prepared synthetically. For example, the valerate, laurate, oleate, linoleate and caproate esters of the carotenoids zeaxanthin and isozeaxanthin have been described in U.S. Pat. No. 5,536,504 of Eugster, et al. Short chain organic acid diesters of lutein and zeaxanthin have also been described in U.S. Pat. No. 5,959,138 of Torres-Cardona, et al.
Esters containing a carotenoid as the acid-derived moiety are also well known. Whereas many occur in nature (“
Key to Carotenoids
”), other esters of this type have been prepared by synthesis. For example, U.S. Pat. No. 2,768,198 of Marbet, et al. describes the preparation of esters of bixin and norbixin with amyl alcohol, octyl alcohol and Vitamin A.
Finally, glycerides with a carotenoid acid have been prepared by enzymatic catalysis (Partali et al,
Angew. Chem Int. Ed. Engl.
35:329-330 (1996)). The reaction of &bgr;-apo-8′-carotenoic acid with Vitamin E yields &agr;-tocopheryl-&bgr;-8′-carotenoate as described by Larsen et al (
Chem. Eur. J.
4:113-117 (1998)). Additionally, the enzymatic esterification of bixin using L-ascorbic acid, which contains two alcoholic OH groups, as the alcohol moiety has been reported by Humeau et al (
Biotechnol. Lett.
22:155-168 (2000)).
In summary, although many esters containing carotenoid components are known, all of the known carotenoid esters contain a non-carotenoid component as the alcohol-derived moiety or the acid-derived moiety.
BRIEF SUMMARY OF THE INVENTION
This invention is directed to esters comprising at least one alcohol-derived moiety and at least one acid-derived moiety, wherein the at least one alcohol-derived moiety comprises a hydroxy carotenoid selected from the group consisting of monohydroxy carotenoids, dihydroxy carotenoids, and polyhydroxy carotenoids, and wherein the acid-derived moiety comprises a carboxylic carotenoid selected from the group consisting of monocarboxylic carotenoids, dicarboxylic carotenoids, and polycarboxylic carotenoids. Preferred hydroxy carotenoids include lutein, zeaxanthin, cryptoxanthin, violaxanthin, carotene diol, hydroxy carotene, hydroxylycopene, alloxanthin and dehydrocryptoxanthin. Preferred carboxylic carotenoids include bixin, norbixin, &bgr;-apo-8-carotenoic acid, crocetin, diapocarotenoic acid, carboxylcarotene and azafrin.
REFERENCES:
patent: 2768198 (1956-10-01), Marbet et al.
patent: 3206316 (1965-09-01), Kläui
patent: 5536504 (1996-07-01), Eugster et al.
patent: 5959138 (1999-09-01), Torres-Cardona et al.
patent: 6191293 (2001-02-01), Levy
patent: 199 50 327 (2000-04-01), None
patent: WO 98/45241 (1998-10-01), None
Chew, et al., “Effects of Lutein from Marigold Extract on Immunity and Growth of Mammary Tumors in Mice”,Anticancer Research, vol. 16, pp. 3689-3694, (1996).
Landrum, et al., “Lutein, Zeaxanthin, and the Macular Pigment”,Archives of Biochemistry and Biophysics, 385:1, pp. 28-40, (Jan. 1, 2001).
Krinsky, “The Biological Properties of Carotenoids”,Pure&Appl. Chem., 66:5, pp. 1003-1010, (1994).
Straub, “Key to Carotenoids”,Institute of Organic Chemistry University of Berne, 2ndand Revised Edition, (1987).
ALAM, et al., “Fatty Acid Composition of the Xanthophyll Esters ofTagetes erctaPetals”,Lipids, 3:2, pp. 183-184, (Mar. 1968).
Partali, et al., “Stable, Highly Unsaturated Glycerides—Enzymatic Synthesis with a Carotenoic Acid”,Angew. Chem. Int. Ed. Engl., 35:3, pp. 329-331, (1996).
Larsen, et al., “Combination of Vitamin E with a Carotenoid: &agr;-Tocopherol and Trolox Linked to &bgr;-Apo-8′-carotenoic Acid”,Chem. Eur. J., 4:1, pp. 113-117, (1998).
Humeau, et al., “Enzymatic Esterification of Bixin by L-ascorbic Acid”,Biotechnol. Lett., 22:2, (2000) Abstract Only.
Gann, et al., “Lower Prostate Cancer Risk in Men with Elevated Plasma Lycopene Levels: Results of a Prospective Analysis”,Cancer Research, vol. 59, pp. 1225-1230, (Mar. 15, 1999).
Ziegler, “Carotenoids, Cancer, and Clinical Trials”,Annals of the New York Academy of Sciences, vol. 691: “Carotenoids in Human Health”, pp. 111-119, (1993).
Roth, “Current Chemotherapy and Infectious Diseases”, (Nelson, et al., Eds. American Society of Microbiology: Washington, D.C., pp. 1503-1505, (1980). [Out of Print and No Longer Available].
Binnington Richard H.
Levy Luis W.
Tabatznik Anthony S.
Akin Gump Strauss Hauer & Feld L.L.P.
Carr Deborah D.
LandOfFree
Carotenoid esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carotenoid esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carotenoid esters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3112888